Michel Alchoueiry

6PUBLICATIONS
61CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)NanomedicineMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 06, 2025
Targeting FSP1 to induce ferroptosis in chromophobe renal cell carcinoma.

Samer Salem, Tiegang Han, Michel Alchoueiry

|Jul 02, 2025
Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell Carcinoma.

Chris Labaki, Eddy Saad, Katrine N Madsen

|Sep 28, 2024
Guiding the future of clinical care and clinical research in Birt-Hogg-Dubé.

Michel Alchoueiry, W Clark Lambert, Elizabeth P Henske

|Jan 09, 2024
TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex.

Nicola Alesi, Damir Khabibullin, Dean M Rosenthal

|Jan 21, 2023
Epigenomic charting and functional annotation of risk loci in renal cell carcinoma.

Amin H Nassar, Sarah Abou Alaiwi, Sylvan C Baca

|Jul 22, 2022
Hypersensitivity to ferroptosis in chromophobe RCC is mediated by a glutathione metabolic dependency and cystine import via solute carrier family 7 member 11.

Long Zhang, Charbel S Hobeika, Damir Khabibullin

Pageof 1